# Fermented Black Soybean and Dehulled Adlay Improve Metabolic Syndrome via AMPK–SIRT1 Activation and Gut Microbiota Modulation

**Authors:** Ya-Ru Kuo, Yi-Wei Zheng, Pin-Yu Ho, Yi-Chen Lo, Po-Jung Tsai, Min-Hsiung Pan

PMC · DOI: 10.1021/acs.jafc.5c15101 · 2026-02-23

## TL;DR

Fermented black soybean and adlay help reduce metabolic syndrome symptoms in mice by improving gut health and metabolic pathways.

## Contribution

The study shows fermentation enhances the health benefits of black soybean and adlay through gut microbiota and metabolic pathway modulation.

## Key findings

- FBA reduced body weight, fat, and liver fat in mice on a high-fat diet.
- FBA improved insulin sensitivity and lipid metabolism via AMPK–SIRT1 and PI3K–Akt pathways.
- FBA reversed gut dysbiosis and lowered the Firmicutes-to-Bacteroidetes ratio.

## Abstract

This study investigated the metabolic efficacy ofBacillus subtilis-fermented black soybean and dehulled
adlay (FBA) compared to its unfermented black soybean and dehulled
adlay (UFBA) in high-fat, high-fructose-diet (HFFD)-fed C57BL/6J mice.
FBA supplementation exhibited superior effects in attenuating body
weight gain, visceral adiposity, dyslipidemia, and hepatic steatosis
while improving insulin sensitivity. These benefits were consistent
with the modulation of hepatic AMPK–SIRT1 and PI3K–Akt
signaling pathways, suggesting enhanced lipid oxidation and suppressed
lipogenesis. Furthermore, FBA restructured the gut microbiota by reversing
HFFD-induced dysbiosis, notably decreasing the Firmicutes-to-Bacteroidetes
(F/B) ratio and specifically elevating cecal propionate levels. These
findings demonstrate that fermentation significantly potentiates the
bioactivity of the substrate, suggesting FBA as a potential dietary
strategy that may attenuate metabolic syndrome (MetS) features.

## Linked entities

- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), SIRT1 (sirtuin 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1)
- **Diseases:** metabolic syndrome (MONDO:0000816)

## Full-text entities

- **Genes:** Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, GAPDH [NCBI Gene 547514], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Acc (anterior capsular cataract) [NCBI Gene 104371], Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Scd1 (stearoyl-Coenzyme A desaturase 1) [NCBI Gene 20249] {aka Scd, Scd-1, ab}, Stk11 (serine/threonine kinase 11) [NCBI Gene 20869] {aka Lkb1, Par-4}, Cpt1a (carnitine palmitoyltransferase 1a, liver) [NCBI Gene 12894] {aka C730027G07, CPTI, Cpt1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Lep (leptin) [NCBI Gene 16846] {aka ob, obese}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, PI3K [NCBI Gene 547983]
- **Diseases:** dysbiosis (MESH:D064806), adipocyte hypertrophy (MESH:D006984), weight loss (MESH:D015431), insulin resistance (MESH:D007333), Inflammatory (MESH:D007249), MetS (MESH:D024821), hyperglycemia (MESH:D006943), lipid metabolism disorders (MESH:D052439), dyslipidemia (MESH:D050171), hypertension (MESH:D006973), hepatomegaly (MESH:D006529), impaired glucose tolerance (MESH:D018149), Metabolic disorders (MESH:D008659), metabolic dysregulation (MESH:D021081), abdominal obesity (MESH:D056128), hepatic lipid (MESH:D011017), visceral adiposity (MESH:D007418), chronic (MESH:D002908), weight gain (MESH:D015430), hepatic steatosis (MESH:D005234), obese (MESH:D009765), adipose tissue dysfunction (MESH:D018205), constipation (MESH:D003248), HFFD (MESH:D008228)
- **Chemicals:** butyrate (MESH:D002087), isoflavones (MESH:D007529), phosphoric acid (MESH:C030242), UA (MESH:D014527), Propionate (MESH:D011422), DPPH (MESH:C004931), TG (MESH:D014280), oil (MESH:D009821), fatty acid (MESH:D005227), Paraffin (MESH:D010232), ethyl acetate (MESH:C007650), Fat (MESH:D005223), FBA (-), H&amp;E (MESH:D006371), gold (MESH:D006046), methanol (MESH:D000432), PUFA (MESH:D005231), hematoxylin (MESH:D006416), gallic acid (MESH:D005707), NAD+ (MESH:D009243), eosin (MESH:D004801), acetate (MESH:D000085), heparin (MESH:D006493), anthocyanins (MESH:D000872), SDS (MESH:D012967), PVDF (MESH:C024865), cholesterol (MESH:D002784), APS (MESH:C031276), 4-methylvaleric acid (MESH:C034527), formalin (MESH:D005557), acrylamide (MESH:D020106), Glucose (MESH:D005947), sulfuric acid (MESH:C033158), coixan (MESH:C048343), SCFA (MESH:D005232), gamma-PGA (MESH:C511775), glycine (MESH:D005998), blood glucose (MESH:D001786), loperamide (MESH:D008139), water (MESH:D014867), polyphenol (MESH:D059808), ND (MESH:D009354), fructose (MESH:D005632), TEMED (MESH:C005798), CO2 (MESH:D002245), sucrose (MESH:D013395), Lipid (MESH:D008055), peptides (MESH:D010455), FFA (MESH:D005230), Oil Red O (MESH:C011049), malonyl-CoA (MESH:D008316)
- **Species:** Muribaculum (genus) [taxon 1918540], Mus musculus (house mouse, species) [taxon 10090], Dubosiella (genus) [taxon 1937008], Kineothrix (genus) [taxon 2163168], Coix lacryma-jobi (Job's tears, species) [taxon 4505], Clostridium (genus) [taxon 1485], Homo sapiens (human, species) [taxon 9606], Lactobacillus (genus) [taxon 1578], Glycine max (soybean, species) [taxon 3847], Bacillus subtilis (species) [taxon 1423], Faecalibaculum (genus) [taxon 1729679], Bacillus subtilis subsp. subtilis (subspecies) [taxon 135461], Bacillus subtilis subsp. natto (subspecies) [taxon 86029], Erysipelotrichia (class) [taxon 526524]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964532/full.md

---
Source: https://tomesphere.com/paper/PMC12964532